Dr. Virginia Catherine Clark, MD

Dr. Clark practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Clark's NPI, 1386728475, was assigned on October 25, 2006. Dr. Clark graduated from Emory School of Medicine in 2000. Dr. Clark holds Florida license ME99438.

Dr. Clark's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Clark's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clark practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Clark's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Clark is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Clark's licenses on file in 2 states: Florida and Tennessee.

Dmand AI lists acid reflux, cirrhosis, cirrhosis of the liver, colonoscopy, fatty liver, gastrointestinal inflammation, liver disease and upper GI endoscopy among the conditions Dr. Clark treats.

CMS data shows 482 Medicare services from Dr. Clark across 11 procedure codes in 2024, for 298 Medicare patients. Medicare paid $32,400 for them.

CMS counts 298 Medicare patients who saw Dr. Clark in 2024. The largest group is 65 to 74, with 152 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Clark's median patient age at 69, with 56% women.

In 2024, Dr. Clark wrote 465 Medicare Part D claims for 78 patients. 77% of them were for generic drugs. CMS names the drug for 356 of them, across 11 drugs with 11 or more claims each, at $252,922 in total drug cost. In 2023, CMS named 230 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Clark for performance year 2024, reported through an alternative payment model (APM). Dr. Clark accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 20 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Clark, more than 50% of the clinicians it reports for that procedure.

Dmand AI links 40 papers to Dr. Clark, published from 2007 to 2025. 2019 was the busiest year, with 5. The most frequent topics are alpha 1-Antitrypsin Deficiency, Liver Cirrhosis and Hepatitis C. Dr. Clark has published most often in Aliment Pharmacol Ther. Dr. Clark's most frequent co-authors are Consuelo C. Soldevila-Pico, MD, Roniel Cabrera, MD and Mark Louis Brantly, MD.

Dmand AI links Dr. Clark to 1 clinical trial. Conditions studied include alpha 1-Antitrypsin Deficiency and Subcutaneous Emphysema.

CMS Open Payments shows 34 general payments to Dr. Clark from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 49% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $32,799. It also lists 18 research payments totaling $6,347 from 2021 to 2023.

Dmand AI lists 1 award for Dr. Clark, most recently CMS Stage 1 EHR in 2013.

Dr. Clark graduated from Emory School of Medicine in 2000. Dr. Clark is a member of AASLD.

Dr. Clark is in network with 16 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.